In the Spotlight

New Milestones publication now available

Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 10 of our top scientific advances from the past year. These discoveries include advances in precision medicine — such as the identification of biomarkers that predict a patient’s response to immunotherapy or lead to health disparities — as well as research on a widely applicable cancer vaccine that could be employed in low-resource settings. Promising research on T cells provides insights into their resilience, behavior and tumor-reactivity with an eye toward developing better immunotherapies, and technological advances provide close-ups of key components of tumor growth and metastasis.

CCR postdoctoral researcher awarded Fulbright to study HPV and cervical cancer in Africa

Tsion Minas, Ph.D., is a recent recipient of a Fulbright U.S. Scholar Award. She joined the Laboratory of Human Carcinogenesis in 2016 to work with Senior Investigator Stefan Ambs, Ph.D., M.P.H., and study the molecular nature of cancers in African populations. In this Q&A, she shares her passion for closing disparity gaps in health research and how she plans to build upon her Fulbright work in the future.

Celebrating Asian American, Native Hawaiian, and Pacific Islander Heritage Month: A Conversation with Lilian Yang, M.B.A.

Lilian Yang, M.B.A., is the Senior Branch Manager in the Neuro-Oncology Branch (NOB). She is originally from Hawaii and identifies as Chinese American. In this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, she talks to us about the many places she has lived, some valuable business school advice, and the need for Asian representation in leadership roles.

Celebrating AANHPI Heritage Month: A Conversation with Suresh Ambudkar, Ph.D.

Suresh V. Ambudkar, Ph.D., is a Senior Investigator and the Deputy Chief of the Laboratory of Cell Biology. For this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, he answers some questions about his academic, research and personal journey immigrating from India to the United States.

New Milestones publication now available

Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 14 of our top scientific advances from the past year. These discoveries include basic research to understand cancer cells, promising advances in immunotherapy for solid tumors, precision oncology for selecting the best treatment for a patient and new insights into the role of the tumor microenvironment and the microbiota in cancer treatment. Other major advances include new technology development achieved through interdisciplinary teamwork, health disparities research relating to prostate cancer and studies that led to several Food and Drug Administration approvals.

Following the fellowship experience with CCR fellow Martha Teke, M.D.

Martha Teke, M.D., is a research fellow in the Surgical Oncology and Cancer Immunotherapy Research Fellowship Program. In this Q&A, she shares her experience as a clinical fellow at CCR and what impact she hopes to leave in the world of science.

Jennifer N. Brudno, Lekha Mikkilineni and Stephanie L Goff

A conversation with CCR immunotherapy experts

June is Immunotherapy Awareness Month. We asked members of the Surgery Branch about their work with immunotherapy as they continue to make important advances in this growing field.

New Milestones publication now available

Every year, the Center for Cancer Research makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features some of our top scientific advances in the past year at CCR. These discoveries include two new FDA-approved therapies, insights into how to design RNA-targeted therapeutics and new ways to predict treatment outcomes in immunotherapy. Other major advances include the development of new computational tools – for identifying viruses in cancer genomes and to elucidate the consequences of DNA damage – and novel diagnostic tools – one to detect liver cancer, another to precisely detect prostate cancer.

Sarcoma Awareness Month

To recognize Sarcoma Awareness Month this July, we are highlighting our researchers who are advancing research discovery in this field. Learn more...

A Conversation with Christina Annunziata, M.D., Ph.D.

Christina Annunziata, M.D., Ph.D., is an Investigator in the Women’s Malignancies Branch at the Center for Cancer Research. She has spent most of her career studying the molecular underpinnings of ovarian cancer with the goal of discovering novel treatments. In our Q&A, Dr. Annunziata discusses her personal and professional milestones as well as new directions for her research.

Breadcrumb